Oral peptide GLP-1 receptor agonist

Semaglutide 1.5 mg oral once daily (reformulated tablet)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

SEMAR2_PO_1p5MG_QD

Agent: semaglutide
Route: PO
Dose: 1.5 mg
Frequency: QD
Dosing: fixed
Mechanism: Oral semaglutide with absorption enhancer
Trials: 0
Participants in these arms: 0

Bioequivalent to original tablet 3 mg. Pooled with SEMA_PO_3MG_QD only in the prespecified sensitivity analysis.

All doses pooled: Semar2 po
Semaglutide 9 mg oral once daily (reformulated tablet)
Semaglutide 4 mg oral once daily (reformulated tablet)

Semaglutide 1.5 mg oral once daily (reformulated tablet)

Related

Trials